RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
Eone-Diagnomics Genome Center Co. of South Korea will partner with GPBio of China to expand Asian markets for their consumer and genetic analysis services. EDGC is itself a joint venture, formed between San Diego’s Diagnomics and South Korea’s EONE. EDGC offers genomic analysis services and microarrays for genetic disorders and cancer. Headquartered in Shanghai, GPBio plans to build China’s largest human genomic database, with the goal of producing accurate genetic tests.
Source: ChinaBio Today
